Vertex Pharmaceuticals (VRTX) Amortizatization of Intangibles (2010 - 2011)

Vertex Pharmaceuticals (VRTX) recorded quarterly Amortizatization of Intangibles of $6.6 million in Q4 2011, up 145.52% quarter-over-quarter from $2.7 million in Q3 2011, and up 83.66% on a YoY basis from $3.6 million in Q4 2010.

Vertex Pharmaceuticals (VRTX) Amortizatization of Intangibles (2010 - 2011) Analysis & Trends

Vertex Pharmaceuticals' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $6.6 million for Q4 2011.

  • In Q4 2011, Amortizatization of Intangibles rose 83.66% year-over-year to $6.6 million; the TTM figure through Dec 2011 stood at $19.4 million (up 42.73% YoY), while the FY2011 annual figure was $18.4 million, up 35.47% from the prior year.
  • Amortizatization of Intangibles was $6.6 million for Q4 2011 at Vertex Pharmaceuticals, up from $2.7 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $6.6 million in Q1 2011 to a low of $2.7 million in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - 13,267.00
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn -
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn -
9 Abivax 93.46 Bn 93.46 Bn - -
10 Regeneron Pharmaceuticals 63.55 Bn 54.80 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2011 6.55 Mn
Dec 31, 2011 6.55 Mn
Sep 30, 2011 2.67 Mn
Sep 30, 2011 2.67 Mn
Mar 31, 2011 6.61 Mn
Mar 31, 2011 6.61 Mn
Dec 31, 2010 3.57 Mn
Dec 31, 2010 3.57 Mn
Sep 30, 2010 3.45 Mn
Sep 30, 2010 3.45 Mn
Jun 30, 2010 3.34 Mn
Jun 30, 2010 3.34 Mn
Mar 31, 2010 3.23 Mn
Mar 31, 2010 3.23 Mn